high smoking prevalence, a sedentary lifestyle, low forced expiratory volume in first second (FEV 1 ) (13) , platelet activation, hypercoagulability, and oxidative stress are possible important contributors (7, 14) . Patients with COPD are subjected to hypoxia, either sustained or intermittent, during exercise or exacerbations. Chronic intermittent hypoxia is associated with hyperlipidemia, atherosclerosis, and a high cardiovascular risk; and the severity of atherosclerosis correlates with the severity of hypoxia (15) . Moreover, abnormalities of the arterial wall extracellular matrix as a result of elastin degradation in the lungs (resulting in emphysema), and in the vasculature (resulting in atherosclerosis) (16) could be a possible mechanism. Among these factors, systemic inflammation was thought to be the most obvious risk factor (13) .
There is increasing evidence that non-invasive imaging modalities, such as ultrasonography, may be able to detect subclinical atherosclerotic lesions (17) . Carotid intima-media thickness (CIMT) measured by carotid Doppler ultrasound is an effective, reliable, and validated method for evaluating carotid atherosclerosis (18) . Measurement of the CIMT by ultrasound can detect thickening of the artery wall during the initial phases of atherosclerosis before the lumens become compromised (19) .
Increased IMT was connected to increased cardiovascular morbidity in patients with COPD (4). However, the clinical relevance of these observations remains unknown in patients with COPD (17) . Accordingly, the aim of this study was to assess atherosclerotic comorbidity in COPD patients and its relation to COPD severity, hypoxemia, and hypercapnia.
METHODS

Study Design
This was a hospital-based observational case-control study conducted from December 2014 to January 2016.
Sample and Place of Study
The study was conducted on 172 participants [86 COPD patients and 86 non-COPD subjects (controls)]. It was carried out at the Chest Diseases Department, Al-Zahraa University Hospital, Cairo, Egypt.
Selection of Subjects 1. COPD group:
The diagnosis and staging of COPD were based on the GOLD, 2014 criteria (post-bronchodilator FEV 1 /FVC<0.7) and an increase in FEV 1 <200 mL, or <12% of the baseline value 20 minutes after 200 µg puffs of inhaled Salbutamol (given via a metered-dose inhaler at the time of diagnosis) (20). 2. Non-COPD group: An equal number of age and sex-matched healthy volunteers with spirometric indices and arterial blood gases (ABG) parameters within the normal range and no history of chronic chest diseases.
Exclusion Criteria
Subjects with systemic hypertension, diabetes mellitus, atherosclerosis, dyslipidemia, known CVD/cerebrovascular diseases, or history of lipid lowering drugs intake were excluded from the study.
Age, smoking frequency (pack/year), and body mass index (BMI) were recorded; and all participants were subjected to the following: (23) . Accordingly, we have evidence to support the reliability of measurements between the three investigators. The measurements of the pilot test were not included in the sample of this study.
Intima-media thickness was measured by ultrasonography using the longitudinal axis of both common carotid arteries (CCA) while the patient lying in the supine position with neck rotated to the opposite side of examination. The exams were performed using a B-mode ultrasound with a Sonoscape A8 (Medical Systems, Shenzhen, China), using a 10-12 MHz linear transducer. Optimal B-mode settings of gain, depth of placement, and compression were individually adjusted for each vessel to enhance arterial wall structures and image quality, in accordance with IMT measurement protocols (24) . The normal thickness of the intima-media complex measured in the B-mode [from the lumen-intima interface (the first hyperechoic line) to the media-adventitia interface (the second hyperechoic line)] was 0.5-0.6 mm and increased somewhat with age ( Figure 1 ) (25) . Bilateral carotid arteries were evaluated and CCA-IMT was measured. At least three IMT measurements were obtained for each near and far wall.
Mean CIMT values from the far walls of both the right and left CCAs (mean-mean) were reported (26, 27) . CIMT values ≥0.8 mm were defined as the cut-off value for a thickened CIM complex ( Figure 2 ) (8).
Ethical Considerations
This study was approved by the ethical review committee of the Faculty of Medicine for Girls Al-Azhar University, Cairo, Egypt. Participation was voluntary; an informed consent was obtained from each study participant. Each participant had the right to refuse participation or withdraw from the study at any point without giving any reasons and without affecting their rights of medical care. Also, data were anonymous and coded to assure confidentiality of participants.
Statistical Analysis
Data was statistically analyzed by the Statistical Package for Social Science (SPSS) program version 17.0 (SPSS Inc.; Chicago, USA). Descriptive analysis was done for each item and the results were expressed as mean ± SD for quantitative continuous variables, and as percentages for qualitative (categorical and nominal) variables. The studied COPD cases were categorized into two groups based on their CIMT. Comparisons to assess the difference between the groups used the Chi-square (X 2 ) test for qualitative data and the Student's t-test for quantitative data (the Shapiro-Wilk test was used for testing normality of the studied variables). The odds ratio was calculated to measure the association between the risk factors and the outcome. Multivariate logistic regression analysis was used to identify the most relevant risk factors affecting thickness of the carotid intima among patients with COPD. The strength of relevance between the risk factors and the outcome was determined according to the value of the Beta coefficient (B), and significance according to the Wald Chi-square test; also, the Odds ratio (OR) was calculated. Analysis of inter-observer reliability was made with the ICC and CI of 95%. Agreement levels were classified as poor (<0.20), fair (0.21-0.40), moderate (0.41-0.60), good (0.61-0.80), and excellent (>0.80) (23) . Statistical significance was considered at a p-value <0.05 (with a confidence limit at 95%). Results are presented in tables and figures. Table 1 shows that the smoking frequency (pack/year) was significantly higher (p=0.001), while spirometric-indices were significantly lower in the COPD group than the non-COPD group. CIMT was signifi- % were significantly lower in COPD patients with a thickened CIMT compared to COPD patients with a normal CIMT. There was no significant difference between both groups regarding BMI, smoking history (OR<1), smoking frequency (pack/year), and airflow limitation (OR=2.195. %CI 0.846-5.19). Thickened CIMT in COPD patients was significantly associated with hypoxemia (OR=8.2, 95% CI, 2.1-33.0) and hypercapnia (OR=6.2, 95% CI, 1.68-22.9). These findings indicate that COPD patients with hypoxemia had an 8-fold increased risk for developing atherosclerosis while COPD patients with hypercapnia had a 6-fold increased risk of developing atherosclerosis. Table 3 shows that CIMT was significantly increased in COPD patients with hypoxemia compared to COPD patients without hypoxemia (p=0.008), and in COPD patients with hypercapnia compared to COPD patients without hypercapnia (p=0.04). No significant difference in CIMT was found among different stages of COPD severity (p=0.83). The Table 4 multivariate logistic regression analysis revealed that the most significant risk factors relevant to the thickened carotid intima among patients with COPD were age (B=0.139) followed by PaO 2 (B=−0.1). Both PaCO 2 and FEV 1 % (B=0.056 and −0.016, respectively) were insignificantly relevant to a thickened CIMT. Moreover, smoking frequency (pack/year) was not relevant to a thickened carotid intima (B=0.000).
RESULTS
DISCUSSION
There is increasing awareness that the inflammatory state associated with COPD is not confined to the lungs, but also involves the whole circulation system and can affect extra-pulmonary organs (28) . These comorbidities account for more than 50% of COPD-related health costs (29) . Thus, it is important to evaluate COPD patients for these comorbidities.
In the current study, 64% of COPD patients (versus 8.1% of healthy controls) had a thickened CIMT. In the same context, other investigators reported a higher prevalence of thickened CIMT in patients with COPD than the control group (8, 17, 30, 31) , Furthermore, Chindhi Table 2 . Comparison between COPD with normal CIMT and COPD with thickened CIMT group in regards to personal characteristics, spirometric indices and carotid thickness et al. (32) documented that the prevalence of carotid plaque formation was significantly higher among COPD patients compared to the controls. Additionally, CIMT was found to be significantly higher among our study COPD patients than the controls (0.85±0.18 mm vs. 0.63±0.076 mm, p<0.001). These results coincide with the results of other studies in the literature (4, 17, (33) (34) (35) (36) (37) (38) (39) .
Although, smoking is a well-known risk factor for atherosclerosis; results of this study revealed that smoking was not relevant to an increased CIMT among the studied COPD patients both by logistic regression analysis and by estimation of risk (OR<1) ( Table 2, 4) . Similar results were reported by other investigators (38); they found that smoking frequency (pack/year) did not differ between COPD patients with normal CIMT and those with a thickened CIMT. Two other studies reported that CIMT was significantly increased: in smoker COPD patients compared to the smoker control group (37) and in smokers with airflow limitation compared to smokers in the control group and never-smokers in the control group (40) . This might be an indication of the influence of other factors leading to intimal thickening other than smoking.
This study demonstrated that FEV 1 % was significantly lower in COPD patients with a thickened CIMT compared to those with a normal CIMT; however, CIMT did not differ significantly between the mild-to-moderate and severe-to-very severe COPD patients. These findings indicate that atherosclerosis initiated in the early stages of COPD and it also suggests that airflow limitation is associated with atherosclerosis. These results are supported by many studies that reported significantly higher CIMT in COPD patients with a lower FEV 1 (41) (42) (43) (44) (45) , and it was not significant between different COPD stages (8, 32) . In addition, van Gestel et al. (17) documented that moderate-to-severe COPD was independently associated with increased CIMT, regardless of the smoking status. In the same context, Anthonisen et al. (46) reported that, for every 10% decrease in FEV 1 , there was a 20% increase in non-fatal coronary events and 28% increase in fatal coronary events among patients with mild-to-moderate COPD. However, other investigators reported that FEV 1 % was not significantly different between COPD patients with normal CIMT and those with a thickened CIMT (38) .
Our data demonstrated that PaO 2 was significantly lower, while PaCO 2 was significantly higher, in COPD patients with a thickened CIMT compared those with a normal CIMT. These results suggest that COPD-related hypoxemia and/or hypercapnia are relevant factors for atherosclerosis. Hypoxemia could lead to atherosclerosis through increasing systemic inflammation, oxidative stress, upregulating cell adhesion molecules, inducing hemodynamic stress, and increased foam cell production (15, 47, 48) . The same results were recorded by Ozbay et al. (36) ; they found that oxygen saturation was decreased in COPD patients with a thickened CIMT and reported that both intermittent and continuous hypoxemia resulted in remarkable alterations in CIMT.
In this study, logistic regression analysis demonstrated that age was a significant risk factor for a thickened intima and this might be explained by degenerative changes that occur with increasing age, including thickening of the vascular intima. This result is concordant with previous work that documents accelerated atherosclerosis of the arterial walls with age and various comorbid risk factors (9) .
The limitation of this study was that the distributions of the groups according to smoking status and COPD stages were relatively heterogeneous.
CONCLUSION
Atherosclerosis was prevalent in about two-thirds (64%) of COPD patients. A thickened CIMT was detected in the early stages of COPD patients and an insignificant difference was found between the mild-moderate to severe-very severe COPD patients. Factors contributing to atherosclerosis in COPD patients included: age, hypoxemia, hypercapnia, and COPD severity. Smoking status as not a contributing factor. Screening for atherosclerosis in COPD patients is recommended for starting early and proper management. Furthermore, interventional studies targeting atherosclerosis as well as studies to evaluate the effects of early oxygen therapy on CIMT in COPD patients are recommended.
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